Use of the CHA2DS2-VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Circulation

• Publication date

  2012-08-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.111.060061PMID 22891166
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapy.

  2013cited by this paper
• Prognosis in Patients with Atrial Fibrillation and CHA2DS2‐VASc Score = 0 in a Community‐Based Cohort Study

  2012cited by this paper
• Approaching the comprehensive management of atrial fibrillation : evolution or revolution ?

  2012cited by this paper
• The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: A nationwide cohort study

  2012cited by this paper
• Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.

  2012cited by this paper
• Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a 'real world' anticoagulated atrial fibrillation population.

  2012cited by this paper
• Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort study.

  2012cited by this paper
• Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012cited by this paper
• RCPE UK Consensus Conference on ‘Approaching the comprehensive management of atrial fibrillation: evolution or revolution?’

  2012cited by this paper
• Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study.

  2012cited by this paper
• Reliable Identification of “Truly Low” Thromboembolic Risk in Patients Initially Diagnosed With “Lone” Atrial Fibrillation: The Belgrade Atrial Fibrillation Study

  2012cited by this paper
• Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a ‘real world’ atrial fibrillation population: A modelling analysis based on a nationwide cohort study

  2011cited by this paper
• Bleeding risk assessment and management in atrial fibrillation patients

  2011cited by this paper
• A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.

  2011cited by this paper
• Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study

  2011cited by this paper
• Validation of the CHADS2 clinical prediction rule to predict ischaemic stroke

  2011cited by this paper
• The role of aspirin for stroke prevention in atrial fibrillation

  2011cited by this paper
• Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review.

  2011cited by this paper
• Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study

  2011cited by this paper
• A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

  2010cited by this paper
• Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

  2010cited by this paper
• The CHADS2 score for stroke risk stratification in atrial fibrillation – friend or foe?

  2010cited by this paper
• Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

  2010cited by this paper
• Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

  2010cited by this paper
• Underuse of oral anticoagulants in atrial fibrillation: a systematic review.

  2010cited by this paper
• Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis.

  2010cited by this paper
• Potentially Preventable Strokes in High-Risk Patients With Atrial Fibrillation Who Are Not Adequately Anticoagulated

  2009cited by this paper
• Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation: The Atrial Fibrillation Investigators

  2009cited by this paper
• Comparison of 12 Risk Stratification Schemes to Predict Stroke in Patients With Nonvalvular Atrial Fibrillation

  2008cited by this paper
• Independent predictors of stroke in patients with atrial fibrillation

  2007cited by this paper
• Development of a contemporary bleeding risk model for elderly warfarin recipients.

  2006cited by this paper
• Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF).

  2006cited by this paper
• Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

  2001cited by this paper
• Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism.

  1999cited by this paper
• Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials.

  1998cited by this paper
• Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin.

  1998cited by this paper

• The impact of ischemic stroke and intracerebral hemorrhage with non-Vitamin K antagonist oral anticoagulants in patients with paroxysmal and persistent atrial fibrillation: A population based cohort study

  2026cites this paper
• Need for Engagement in Stroke Prevention Shared Decision-Making in Older Adults with Atrial Fibrillation and Multimorbidity

  2025cites this paper
• Perioperative Anticoagulation and Risk Assessment: Building a Bridge Over a STREAM

  2025cites this paper
• Perioperative Management of Oral Anticoagulation in Patients with Venous Thromboembolism.

  2025cites this paper
• Integrating Complex Selection Rules Into the Latent Overlapping Group Lasso for the Construction of Coherent Prediction Models

  2025cites this paper
• Antithrombotic agents and effect on outcomes in ischemic stroke with atrial fibrillation and large artery atherosclerosis: a real-world study

  2025cites this paper
• Management Challenges of Life-Threatening Thrombosis and Hemorrhage in a Jehovah’s Witness Patient With Hereditary Hemorrhagic Telangiectasia: A Case Report

  2025cites this paper
• Impact of Social Determinants of Health on Primary Adherence of Oral Anticoagulants Among Patients with Newly Diagnosed Atrial Fibrillation

  2025cites this paper
• Clinical Risk Computation by Large Language Models Using Validated Risk Scores

  2025cites this paper
• The B-S2CALED Score’s Utility in Predicting Stroke Risk in Breast Cancer Patients with Atrial Fibrillation

  2025cites this paper
• Apixaban outcomes in atrial fibrillation patients with a single-dose reduction criterion: ASPIRE 1-year results

  2025cites this paper
• Evaluation of clinical outcome and predictive factors for thromboembolism or hemorrhagic complications in patients treated for chronic subdural hematoma. A prospective observational study

  2025cites this paper
• A conceptual model of factors potentially influencing prescribing decisions for chronic conditions: an overview of systematic reviews

  2025cites this paper
• Deep learning models for segmentation and quantification of left atrial appendage volume using noncontrast cardiac computed tomography

  2025cites this paper
• Multifactorial Risk Stratification in Patients with Heart Failure, Chronic Kidney Disease, and Atrial Fibrillation: A Comprehensive Analysis

  2025cites this paper
• The Atrial Fibrillation Registry (The FLOW‐AF Registry): Insights From the United Arab Emirates—Patient Characteristics, Treatment, and One‐Year Outcomes

  2025cites this paper
• Association of Anaesthetists guidelines: the use of blood components and their alternatives

  2025cites this paper
• Peri-procedural Outcomes of Left Atrial Appendage Occlusion in Lower Versus Higher CHA2DS2-VASc Score.

  2025cites this paper
• The Application and Prospects of Smart Wearable Devices in Cardiovascular Care: Focusing on Electrocardiogram Monitoring, Atrial Fibrillation, and Arrhythmia Management

  2025cites this paper
• The prevalence and burden of chronic kidney disease, patterns of anticoagulation prescribing, and major bleeding risk in older adults with atrial fibrillation

  2025cites this paper
• Assessing and Managing Social Isolation and Loneliness by Clinicians in Clinical Cardiovascular Practice

  2025cites this paper
• Atrial fibrillation and ischemic stroke in cancer: the latest scientific evidence, current management, and future directions

  2025cites this paper
• Effect of ABCB1 SNP polymorphisms on the plasma concentrations and clinical outcomes of rivaroxaban in Chinese NVAF patients: a population pharmacokinetic-based study

  2025cites this paper
• Precision Monitoring of Antithrombotic Therapy in Cardiovascular Disease

  2024cites this paper
• Beyond the Beat: A Multifaceted Review of Atrial Fibrillation in Sepsis: Risk Factors, Management Strategies, and Economic Impact

  2024cites this paper
• D-dimer and fibrinogen indicate ischemic risk in patients with atrial fibrillation after percutaneous coronary intervention

  2024cites this paper
• Treatment strategies of the thromboembolic risk in kidney failure patients with atrial fibrillation

  2024cites this paper
• Enhancing stroke risk stratification in atrial fibrillation through non-Newtonian blood modelling and Gaussian process emulation.

  2024cites this paper
• Risk of Major Bleeding, Stroke/Systemic Embolism, and Death Associated With Different Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease

  2024cites this paper
• Lipid control and stroke risk in atrial fibrillation patients treated with direct oral anticoagulants and statins

  2024cites this paper
• Risk of mortality between warfarin and direct oral anticoagulants: population-based cohort studies

  2024cites this paper
• Plasma thrombin generation in the presence of TIX-5 may contribute significantly to a prediction model for major bleeding in patients on VKA anticoagulant therapy

  2024cites this paper
• Atrial Fibrillation Surgery in Australia: Are We Doing Enough?

  2024cites this paper
• Strategies for Identifying Patients for Deprescribing of Blood Pressure Medications in Routine Practice: An Evidence Review

  2024cites this paper
• CHA2DS2-VASc Score in Predicting Visual Acuity Outcomes Following Retinal Vein Occlusion

  2024cites this paper
• Predicting the risk of acute kidney injury in primary care: derivation and validation of STRATIFY-AKI

  2023cites this paper
• Impact of atrial fibrillation type (paroxysmal vs. non-paroxysmal) on long-term clinical outcomes: The RAFFINE registry subanalysis.

  2023cites this paper
• Imaging and biophysical modelling of thrombogenic mechanisms in atrial fibrillation and stroke

  2023cites this paper
• Tachy-Brady Syndrome in a Schizophrenic Patient: A Case Report

  2023cites this paper
• The association between antihypertensive treatment and serious adverse events by age and frailty: A cohort study

  2023cites this paper
• Ablation and Appendage Occlusion for Atrial Fibrillation: Does it Take Two to Tango?

  2023cites this paper
• Influence of thrombocytopenia on bleeding and vascular events in atrial fibrillation

  2023cites this paper
• Use of Non-Vitamin K-Dependent Oral Anticoagulants in Elderly and Fragile Patients with Atrial Fibrillation

  2023cites this paper
• Systematic review of the incidence and clinical risk predictors of atrial fibrillation and permanent pacemaker implantation for bradycardia in Fabry disease

  2023cites this paper
• Diagnosis and Management of Cardiovascular Effects of Bruton's Tyrosine Kinase Inhibitors

  2023cites this paper
• Increased Left Atrial Stiffness is Significantly Associated with Paroxysmal Atrial Fibrillation in Diabetic Patients

  2023cites this paper
• Association of Alternative Anticoagulation Strategies and Outcomes in Patients With Ischemic Stroke While Taking a Direct Oral Anticoagulant

  2023cites this paper
• Effectiveness and safety of secondary prevention of non-vitamin K oral anticoagulants use by drug type in Asian patients

  2023cites this paper
• Diagnosis and Treatment of New-Onset Perioperative Atrial Fibrillation.

  2023cites this paper
• Electronic alerts for ambulatory patients with atrial fibrillation not prescribed anticoagulation: A randomized, controlled trial (AF-ALERT2).

  2023cites this paper
• How We Manage Patients with Indolent B-Cell Malignancies on Bruton’s Tyrosine Kinase Inhibitors: Practical Considerations for Nurses and Pharmacists

  2023cites this paper
• Sex Differences in Quality of Life and their Explanatory Variables in Patients with Non-Valvular Atrial Fibrillation

  2023cites this paper
• Value of D-Dimer in Risk Stratification for Thromboembolism in Patients With Atrial Fibrillation and Low CHA2DS2-VASc Score

  2023cites this paper
• Stroke-Specific Predictors of Major Bleeding in Anticoagulated Patients With Stroke and Atrial Fibrillation: A Nationwide Multicenter Registry-Based Study

  2023cites this paper
• Reduced Left Atrial Appendage Flow Is Associated With Future Atrial Fibrillation After Cryptogenic Stroke.

  2023cites this paper
• Prevalence and Predictors of Inappropriate Antithrombotic Prescription in Patients Presenting With Traumatic Brain Injury

  2023cites this paper
• Differential Inhibition of Platelet Reactivity by Dual Therapy With Aspirin and Low-Dose Rivaroxaban in Peripheral Arterial Disease: A Pilot Study

  2022cites this paper
• Predicting mortality in hospitalized COVID-19 patients

  2022cites this paper
• Perception of atrial fibrillation symptoms: Impact on quality of life and treatment in older adults

  2022cites this paper
• Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation

  2022cites this paper
• Evaluation of an Electronic Health Record Alert to Improve Screening and Management of Cardiovascular Disease and Stroke Factors in a High-Risk Population

  2022cites this paper
• Percutaneous left atrial appendage occlusion: A South African experience.

  2022cites this paper
• Expert Recommendations on the Usage of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) from India: Current Perspective and Future Direction

  2022cites this paper
• Performance of multilabel machine learning models and risk stratification schemas for predicting stroke and bleeding risk in patients with non-valvular atrial fibrillation

  2022cites this paper
• Association between CHADS2, CHA2DS2-VASc, ATRIA, and Essen Stroke Risk Scores and Unsuccessful Recanalization after Endovascular Thrombectomy in Acute Ischemic Stroke Patients

  2022cites this paper
• Costs and Healthcare Resource Utilization Associated with Idarucizumab or Andexanet Alfa Oral Anticoagulant Reversal in Patients Hospitalized with Life-Threatening Bleeds

  2022cites this paper
• Healthcare Resource Utilization for Oral Anticoagulant Reversal Therapies in Non-Valvular Atrial Fibrillation/Venous Thromboembolism Patients

  2022cites this paper
• Apixaban Versus Rivaroxaban in Patients With Atrial Fibrillation and Valvular Heart Disease

  2022cites this paper
• Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis

  2022cites this paper
• Current Advancement in Diagnosing Atrial Fibrillation by Utilizing Wearable Devices and Artificial Intelligence: A Review Study

  2022cites this paper
• Association between CHADS2, CHA2DS2-VASc, ATRIA, and Essen Stroke Risk Scores and Functional Outcomes in Acute Ischemic Stroke Patients Who Received Endovascular Thrombectomy

  2022cites this paper
• Decision of Anticoagulation in Nonvalvular Atrial Fibrillation in the Real World in the Non-Antivitamin K Anticoagulants Era

  2022cites this paper
• Comparison of In-Hospital Outcomes After Insertion of Watchman Device in Men Versus Women (from the National Inpatient Data).

  2022cites this paper
• Effectiveness and Safety of Direct Oral Anticoagulants in Thai Patients with Atrial Fibrillation: A Real-World Retrospective Cohort Study

  2022cites this paper
• Eligibility and Implementation of Rivaroxaban for Secondary Prevention of Atherothrombosis in Clinical Practice—Insights From the CANHEART Study

  2022cites this paper
• A retrospective study of real-world effectiveness and safety of rivaroxaban in patients with non-valvular atrial fibrillation and venous thromboembolism in Saudi Arabia

  2022cites this paper
• Effects of sociodemographic and socioeconomic factors on stroke development in Lebanese patients with atrial fibrillation: a cross-sectional study.

  2021cites this paper
• Impact of the Pattern of Atrial Fibrillation on Stroke Risk and Mortality

  2021cites this paper
• Artificial intelligence MacHIne learning for the detection and treatment of atrial fibrillation guidelines in the emergency department setting (AIM HIGHER): Assessing a machine learning clinical decision support tool to detect and treat non‐valvular atrial fibrillation in the emergency department

  2021cites this paper
• Cardiovascular and major bleeding outcomes with antiplatelet and direct oral anticoagulants in patients with acute coronary syndrome and atrial fibrillation A population-based analysis.

  2021cites this paper
• ACCIDENTE CEREBROVASCULAR Y FIBRILACIÓN AURICULAR EN UNA INSTITUCIÓN PRESTADORA DE SALUD DEL QUINDÍO

  2021cites this paper
• Role of SARS CoV2 IGG Antibody Beyond Sero-surveillance.

  2021cites this paper
• Many Good Reasons to Switch from Vitamin K Antagonists to Non-Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation

  2021cites this paper
• Bruton’s tyrosine kinase Inhibitors and Cardiotoxicity: More Than Just Atrial Fibrillation

  2021cites this paper
• Temporal Trends of Transcatheter Edge-to-Edge Repair of the Mitral Valve Short-Term Outcomes in the United States: Nationwide Representative Study

  2021cites this paper
• Perioperative management in cardiovascular surgery

  2021cites this paper
• Influence of CYP2C9, VKORC1, and CYP4F2 polymorphisms on the pharmacodynamic parameters of warfarin: a cross-sectional study

  2021cites this paper
• Adherence to anticoagulant guideline for atrial fibrillation: A large care gap among stroke patients in a rural population.

  2021cites this paper
• Evaluation of pharmacokinetics of warfarin from validated pharmacokinetic-pharmacodynamic model

  2021cites this paper
• Reversing the Effect of Anticoagulants Safety in Patients Undergoing Emergency Surgery

  2021cites this paper
• Drugs in phase I and II clinical development for the prevention of stroke in patients with atrial fibrillation

  2021cites this paper
• Risks of post-colonoscopic polypectomy bleeding and thromboembolism with warfarin and direct oral anticoagulants: a population-based analysis

  2021cites this paper
• Perioperative management and optimization of atrial fibrillation for noncardiac surgery

  2021cites this paper
• Genetic-Guided Pharmacotherapy for Atrial Fibrillation: A Systematic and Critical Review of Economic Evaluations.

  2021cites this paper
• Association of Type of Antidepressant Initiation with Bleeding Risk in Atrial Fibrillation Patients Taking Oral Anticoagulants

  2021cites this paper
• Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology.

  2021cites this paper
• The role of biomarkers and neuroimaging in ischemic/hemorrhagic risk assessment for cardiovascular/cerebrovascular disease prevention.

  2021cites this paper
• Effects of sociodemographic and socioeconomic factors on stroke development in Lebanese patients with atrial fibrillation: a cross-sectional study

  2021cites this paper
• Atrial Fibrillation and Stroke.

  2021cites this paper
• Patients’ time in therapeutic range on warfarin among atrial fibrillation patients in Warfarin Medication Therapy Adherence Clinic

  2021cites this paper